Carcinogenicity and toxicity of 1,2-dibromoethane in the rat,☆☆

https://doi.org/10.1016/0041-008X(82)90036-9Get rights and content

Abstract

A chronic inhalation study of ethylene dibromide (EDB) was conducted in Sprague-Dawley rats. Four groups of rats received either control air, 0.05% disulfiram in the diet, 20 ppm of EDB, or 20 ppm of EDB and 0.05% disulfiram in the diet for 18 months. Rats receiving 20 ppm of EDB had high mortality and an increase, compared to controls, in one or both sexes of tumor incidences in the mammary gland, spleen, adrenal, liver, kidney, and subcutaneous tissue. A combined treatment of 20 ppm of EDB and 0.05% disulfiram in the diet resulted in earlier deaths (all within 14 months) and decreases in body weight gain, food consumption, hemoglobin, hematocrit, and RBC counts. This combination of EDB and disulfiram treatment also caused high incidences of tumors in liver, spleen, kidney, adrenal, thyroid, lung, mesentery, and mammary gland in one or both sexes. Testicular atrophy was found in 90% of the male rats that received a combination of EDB and disulfiram treatment.

References (37)

  • E.S. GouldE.S. Gould
  • J. Graham

    In vitro inhibition of liver aldehydes dehydrogenase by tetraethylthiuram disulphide

    J. Pharm. Pharmacol.

    (1951)
  • E. Jacobsen et al.

    Treatment of alcoholism with tetraethylthiuram disulfide (antibase)

    J. Amer. Med. Assoc.

    (1949)
  • H. Kalant

    Some recent physiological and biochemical investigations on alcohol and alcoholism

    Quart. J. Staud. Alcohol

    (1962)
  • A. Kendorosi et al.

    Inactivation of Q-beta RNA by electrophiles

    Mutat. Res.

    (1973)
  • N.O. Kgeldgaard

    Inhibition of aldehyde oxidase from liver by tetraethylthiuram disulphide (antibuse)

    Acta Pharmacol. Toxicol.

    (1949)
  • M. Kochmann

    Possible industrial poisonings with ethylene dibromide

    Muench. Med. Wochenschr.

    (1928)
  • G. Marmetschke

    On lethal ethyl bromide and ethylene bromide intoxication

    Vieteljahresschr. Gerichtl. Med. Oeff. Sanitaetswes.

    (1910)
  • Cited by (0)

    This research was sponsored by the National Institute for Occupational Safety and Health under Contract 210-76-0131.

    ☆☆

    A preliminary report of this work was presented at the joint meeting of the Society of Toxicology and American Society of Pharmacology and Experimental Therapeutics in Houston, Tex. August 1978.

    3

    Present address: Drug Safety Evaluation, Revlon Health Care Group, Research and Development Division, 1 Scarsdale Road, Tuckahoe, N.Y. 10707.

    4

    Present address: College of Pharmacy, Drake University, Des Moines, Iowa 50311.

    5

    National Institute for Occupational Safety and Health, Robert A. Taft Laboratories, 4676 Columbia Parkway, Cincinnati, Ohio 45226.

    View full text